NWMG
CATX icon

Nicholson Wealth Management Group’s Perspective Therapeutics CATX Stock Holding History

Nicholson Wealth Management Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.75M Buy
1,618,993
+1,000
+0.1% +$4.22K 3.93% 1
2025
Q4 		$4.45M Sell
1,617,993
-300
-0% -$856 2.61% 2
2025
Q3 		$5.55M Buy
1,618,293
+4,010
+0.2% +$14.6K 3.25% 2
2025
Q2 		$5.55M Buy
1,614,283
+5,000
+0.3% +$13.2K 3.42% 2
2025
Q1 		$3.43M Hold
1,609,283
– – 2.25% 2
2024
Q4 		$5.13M Buy
1,609,283
+7,000
+0.4% +$57.2K 3.43% 2
2024
Q3 		$21.4M Buy
+1,602,283
New +$21.3M 17.57% 1

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nicholson Wealth Management Group's CATX Position: Q1 2026 in Review

Nicholson Wealth Management Group increased its Perspective Therapeutics (CATX) stake by 0.06% in Q1 2026, buying an estimated $4.22K and bringing the position to 1,618,993 shares worth $6.75M. The position accounts for 3.93% of the portfolio, ranked #1.

Nicholson Wealth Management Group first reported a position in CATX in Q3 2024 and has held it in 7 quarters since. The position peaked at $21.4M in Q3 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Nicholson Wealth Management Group held 1,618,993 shares of Perspective Therapeutics worth $6.75M as of Q1 2026.
  • Nicholson Wealth Management Group bought 1,000 Perspective Therapeutics shares in Q1 2026, an estimated $4.22K.
  • Perspective Therapeutics made up 3.93% of Nicholson Wealth Management Group's portfolio in Q1 2026, its #1 holding.
  • Nicholson Wealth Management Group first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Nicholson Wealth Management Group's Perspective Therapeutics position peaked at $21.4M in Q3 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Nicholson Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.